TH1201001042B - Highly concentrated, stabilized pharmaceutical formulation of anti-CD20 antibody. - Google Patents

Highly concentrated, stabilized pharmaceutical formulation of anti-CD20 antibody.

Info

Publication number
TH1201001042B
TH1201001042B TH1201001042A TH1201001042A TH1201001042B TH 1201001042 B TH1201001042 B TH 1201001042B TH 1201001042 A TH1201001042 A TH 1201001042A TH 1201001042 A TH1201001042 A TH 1201001042A TH 1201001042 B TH1201001042 B TH 1201001042B
Authority
TH
Thailand
Prior art keywords
antibody
pharmaceutical formulation
highly concentrated
stabilized pharmaceutical
stabilized
Prior art date
Application number
TH1201001042A
Other languages
Thai (th)
Other versions
TH151334A (en
Inventor
ไมเคิลมาห์เลอร์ ฮันส์ คริสเตียนสเตาค์ โอลิเวอร์ บอริส แอดเลอร์
Original Assignee
เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี
Filing date
Publication date
Application filed by เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี filed Critical เอฟ ฮอฟฟ์แมนน์ ลา โรช เอจี
Publication of TH151334A publication Critical patent/TH151334A/en
Publication of TH1201001042B publication Critical patent/TH1201001042B/en

Links

TH1201001042A 2010-09-10 Highly concentrated, stabilized pharmaceutical formulation of anti-CD20 antibody. TH1201001042B (en)

Publications (2)

Publication Number Publication Date
TH151334A TH151334A (en) 2016-05-19
TH1201001042B true TH1201001042B (en) 2016-05-19

Family

ID=

Similar Documents

Publication Publication Date Title
CL2014001930A1 (en) Pharmaceutical formulation comprising an angiopoietin 2 (anti-ang2) antibody.
CL2014003370A1 (en) Stable aqueous composition of anti-baffr antibodies; and composition delivery device.
BR112015003259A2 (en) compound, pharmaceutical composition, and vaccine composition.
BR112015002738A2 (en) compound and pharmaceutical composition
BRPI1012892A2 (en) compound and pharmaceutical composition.
BR112014029403A2 (en) conjugates, antibody and pharmaceutical formulation
IT1403054B1 (en) BOTTLE.
EP3060229A4 (en) Stable, aqueous antibody formulations
BR112013020383A2 (en) lyophilized formulations.
BR112014001274A2 (en) luteinizing hormone compound and pharmaceutical composition
BRPI1016190A2 (en) pharmaceutical compounds.
BR112014009950A2 (en) disubstituted compound, compounds and pharmaceutical composition
BR112015002824A2 (en) compound, use of a compound, pharmaceutical composition, and combination pharmaceutical product.
BR112014009889A2 (en) disubstituted compounds, compounds and pharmaceutical composition
BR112012003800A2 (en) composition, peptide, and pharmaceutical formulation.
BR112013019327A2 (en) compound and composition.
HK1205462A1 (en) Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative
CO6940426A2 (en) Pharmaceutical formulations
DK2486051T3 (en) PHARMACEUTICAL PREPARATION CONTAINING RECOMBINANT HCG
CL2014003283A1 (en) Pharmaceutical formulation
ITTO20121129A1 (en) PROCEDURE FOR PROTECTION OF CORN.
HK1201253A1 (en) Pharmaceutical compositions comprising deuterium-enriched perillyl alcohol, iso-perillyl alcohol and derivatives thereof
BR112012021455A2 (en) pharmaceutical or nutraceutical formulation.
BR112014032501A2 (en) compound and pharmaceutical composition.
FR2958500B1 (en) PREPARATION INSECTICIDE, INSECTIFUGE, OVICIDE, LARVICIDE, NYMPHICIDE